Role of ammonia and inflammation in minimal hepatic encephalopathy
- PMID: 17260161
- DOI: 10.1007/s11011-006-9042-1
Role of ammonia and inflammation in minimal hepatic encephalopathy
Abstract
Background: Minimal hepatic encephalopathy (MHE) is common in cirrhosis but its pathophysiologic basis remains undefined. We evaluated whether the presence of MHE was associated with severity of liver disease, ammonia levels or the presence of inflammation and assessed factors determining neuropsychological deterioration accompanying induction of hyperammonemia.
Methods: Eighty four cirrhotics were studied. A neuropsychological test battery was performed and blood taken for ammonia, WCC, CRP, nitrate/nitrite, IL-6 and amino acids, before and after, induction of hyperammonemia by administration of a solution mimicking the amino acid composition of haemoglobin (60) or placebo (24).
Results: The presence and severity of MHE were independent of severity of liver disease and ammonia concentration but markers of inflammation were significantly higher in those with MHE compared with those without. Induction of hyperammonemia produced deterioration in one or more neuropsychological tests by > or =1 SD in 73.3%. This was independent of the magnitude of change in plasma ammonia and severity of liver disease but was significantly greater in those with more marked inflammation.
Conclusion: Our data show that inflammation is an important determinant of the presence and severity of MHE. The change in neuropsychological function following induced hyperammonemia is greater in those with more severe inflammation.
Similar articles
-
Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis.J Hepatol. 2004 Feb;40(2):247-54. doi: 10.1016/j.jhep.2003.10.016. J Hepatol. 2004. PMID: 14739095
-
Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy.Metab Brain Dis. 2012 Mar;27(1):51-8. doi: 10.1007/s11011-011-9269-3. Epub 2011 Nov 10. Metab Brain Dis. 2012. PMID: 22072427
-
IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy.J Clin Gastroenterol. 2009 Mar;43(3):272-9. doi: 10.1097/MCG.0b013e31815e7f58. J Clin Gastroenterol. 2009. PMID: 18562979
-
Ammonia and beyond - biomarkers of hepatic encephalopathy.Metab Brain Dis. 2025 Jan 15;40(1):100. doi: 10.1007/s11011-024-01512-7. Metab Brain Dis. 2025. PMID: 39812958 Free PMC article. Review.
-
Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.Nutr Clin Pract. 2013 Oct;28(5):580-8. doi: 10.1177/0884533613496432. Epub 2013 Aug 14. Nutr Clin Pract. 2013. PMID: 23945292 Review.
Cited by
-
Extracellular Vesicles from Hyperammonemic Rats Induce Neuroinflammation and Motor Incoordination in Control Rats.Cells. 2020 Feb 28;9(3):572. doi: 10.3390/cells9030572. Cells. 2020. PMID: 32121257 Free PMC article.
-
Gut microbiota-related complications in cirrhosis.World J Gastroenterol. 2014 Nov 14;20(42):15624-31. doi: 10.3748/wjg.v20.i42.15624. World J Gastroenterol. 2014. PMID: 25400446 Free PMC article. Review.
-
Clinical Implications of Inflammation in Patients With Cirrhosis.Am J Gastroenterol. 2025 Jan 1;120(1):65-74. doi: 10.14309/ajg.0000000000003056. Epub 2024 Aug 27. Am J Gastroenterol. 2025. PMID: 39194320 Free PMC article. Review.
-
Modulation of neural activation following treatment of hepatic encephalopathy.Neurology. 2013 Mar 12;80(11):1041-7. doi: 10.1212/WNL.0b013e31828726e1. Epub 2013 Feb 20. Neurology. 2013. PMID: 23427320 Free PMC article.
-
Gut microbiota, inflammation and hepatic encephalopathy: a puzzle with a solution in sight.J Clin Exp Hepatol. 2012 Sep;2(3):207-10. doi: 10.1016/j.jceh.2012.08.004. J Clin Exp Hepatol. 2012. PMID: 25755435 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous